Year1
- 型号：
- 吉非替尼
- 规格：
- 0.25g*30片/盒
- 有效期：
- 24个月
English name
Chinese Pinyin
[Ingredients]
The main ingredient of this product is gefitinib
[Characteristics]
Brown, round, film-coated tablet with printed on one side.
[Indications]
This product is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer that has previously received chemotherapy. Previous chemotherapy treatments mainly referred to platinum and docetaxel treatments.
The efficacy of patients with locally advanced or metastatic non-small cell lung cancer who have failed chemotherapy is established based on objective response rate indicators. There are no controlled studies showing clinical efficacy in improving disease-related symptoms and prolonging survival. Benefit. The existing data on the use of this product in the second-line treatment of non-small cell lung cancer are only based on uncontrolled clinical studies and need to be further confirmed by well-designed controlled clinical trials.
For the first-line treatment of non-small cell lung cancer, the results of two large randomized controlled clinical trials showed that platinum-based dual chemotherapy regimens did not show any benefit after treatment with this product. Therefore, gefitinib is not suitable for this kind of treatment.
[Usage and Dosage]
The recommended adult dose of this product is (tablet), taken orally once a day, on an empty stomach or with food.
【Specifications】
./piece
【Validity Period】
Months
【Storage】
Save below.
【Packaging】
/Aluminum foil blister packaging.
Tablets/box
[Imported drug registration certificate number]
Sub-packaging approval number, national drug approval number
[Manufacturer]
Sub-packaging company name India
Product price (unit yuan)
No. Drug name and generic name Manufacturer and specifications Price and discount
Iressa
Gefitinib tablets
Specifications.*tablets/box Reference price￥yuan
India Pharmaceutical Co., Ltd.
WhatsApp
